Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network.

Hughes TB, Miller GP, Swamidass SJ.

ACS Cent Sci. 2015 Jul 22;1(4):168-80. doi: 10.1021/acscentsci.5b00131. Epub 2015 Jun 9.

2.

Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.

Guleria VS, Sharda C, Rana T, Sood AK.

Indian J Pharmacol. 2015 Jul-Aug;47(4):459-61. doi: 10.4103/0253-7613.161279.

3.

Treatment of epilepsy in China: Formal or informal.

Liu J, Liu Z, Chen T, Xu R.

Neural Regen Res. 2013 Dec 15;8(35):3316-24. doi: 10.3969/j.issn.1673-5374.2013.35.006.

4.

Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndrome.

Schipper S, Gantenbein AR, Maurer K, Alon E, Sándor PS.

Pain Ther. 2013 Jun;2(1):49-56. doi: 10.1007/s40122-013-0007-x. Epub 2013 Feb 15.

5.

New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?

French JA, Gazzola DM.

Ther Adv Drug Saf. 2011 Aug;2(4):141-58. doi: 10.1177/2042098611411127. Review.

6.

Pharmacotherapeutic and Non-Pharmacological Options for Refractory and Difficult-to-Treat Seizures.

Mitchell JW, Seri S, Cavanna AE.

J Cent Nerv Syst Dis. 2012 Jun 19;4:105-15. doi: 10.4137/JCNSD.S8315. Print 2012.

7.

Seizure recurrence and remission after switching antiepileptic drugs.

Wang SP, Mintzer S, Skidmore CT, Zhan T, Stuckert E, Nei M, Sperling MR.

Epilepsia. 2013 Jan;54(1):187-93. doi: 10.1111/j.1528-1167.2012.03652.x. Epub 2012 Aug 29.

8.

A new generation of anticonvulsants for the treatment of epilepsy in children.

Snead OC, Donner EJ.

Paediatr Child Health. 2007 Nov;12(9):741-4.

9.

Comparative monotherapy trials and the clinical treatment of epilepsy.

Abou-Khalil BW.

Epilepsy Curr. 2007 Sep-Oct;7(5):127-9. No abstract available.

10.

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group.

Lancet. 2007 Mar 24;369(9566):1000-15.

11.

Response to First AED.

French JA.

Epilepsy Curr. 2002 May;2(3):72-73. No abstract available.

12.
13.

The promise of new antiepileptic drugs.

Duncan JS.

Br J Clin Pharmacol. 2002 Feb;53(2):123-31. Review.

14.

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.

McKee PJ, Blacklaw J, Forrest G, Gillham RA, Walker SM, Connelly D, Brodie MJ.

Br J Clin Pharmacol. 1994 Jan;37(1):27-32.

15.

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.

Larkin JG, McKee PJ, Forrest G, Beastall GH, Park BK, Lowrie JI, Lloyd P, Brodie MJ.

Br J Clin Pharmacol. 1991 Jan;31(1):65-71.

16.

Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.

Pirmohamed M, Graham A, Roberts P, Smith D, Chadwick D, Breckenridge AM, Park BK.

Br J Clin Pharmacol. 1991 Dec;32(6):741-9.

Items per page

Supplemental Content

Write to the Help Desk